Fidia Farmaceutici, S.p.A. to Distribute and Promote HYALGAN(R) (sodium hyaluronate) for Treatment of Osteoarthritis
9/26/2011 12:13:36 PM
More...
|
Sanofi Release: HYALGAN(R) (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici, S.p.A.
9/15/2011 10:59:53 AM
More...
|
Anika Therapeutics (ANIK) Buys Italian Firm, Fidia Farmaceutici, S.p.A. for $34 Million
1/4/2010 6:55:40 AM
More...
|
Fidia Farmaceutici, S.p.A. Release: Fidia Farmaceutici, S.p.A.'s European Patent on Cross-Linked Gel Slurries Has Been Entirely Revoked by the EPO Board of Appeal
12/2/2008 9:13:14 AM
More...
|
APR Applied Pharma Research S.A. Receive IND Approval From FDA for a New NSAID Matrix Patch Product
11/17/2008 8:43:10 AM
More...
|
Akorn, Inc. (AKRN) Signs A Definitive Agreement With Fidia Farmaceutici, S.p.A. To Develop Four ANDA Drug Products For Commercialization
5/2/2006 11:45:57 AM
More...
|
Akorn, Inc. (AKRN) Signs Letter Of Intent With Fidia Farmaceutici, S.p.A. To Develop Four ANDA Drug Products For Commercialization
10/19/2005 5:13:21 PM
More...
|